Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
ES01 - What Is the Role of Chemotherapy in the Era of Immunotherapy in Advanced NSCLC?
- 10:30 - 12:00
- 9/08/2019
- Location: Hilton Head (1978)
- IASLC CME Accredited
- Type: Educational Session
- Track: Advanced NSCLC
- Moderators:Oscar Gerardo Arrieta, Reyes Bernabe
-
+
ES01.04 - Immunotherapy, Radiotherapy and Chemotherapy Combination: A Potential New Standard?
11:15 - 11:30 | Presenter: Maurice Perol
- Abstract
Loading...
-
+
MA07 - Clinical Questions and Potential Blood Markers for Immunotherapy
- 13:30 - 15:00
- 9/08/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Immuno-oncology
- Moderators:David R Spigel, Roberto Ferrara
-
+
MA07.05 - Immune Checkpoint Inhibitor (ICPi) Re-Challenge: Outcomes Analysis in a French National Cohort of Non-Small-Cell Lung Cancer (NSCLC) Patients
14:00 - 14:05 | Presenter: Elisa Gobbini | Author(s): Anne Claire Toffart, Maurice Perol, Jean-Baptiste Assié, Michael Duruisseaux, Dahna Coupez, Radj Gervais, Virginie Westeel, Myriam Delaunay, Florian Guisier, Remi Veillon, Valérie Gounant, Etienne Giroux Leprieur, François Roger Vanel, Nouha Chaabane, Eric Dansin, Hélène Babey, Chantal Decroisette, Fabrice Barlesi, Nicolas Girard, Pierre Fournel, Laura Mezquita, Youssef Oulkhouir, Anthony Canellas, Boris Duchemann, Olivier Molinier, Denis Moro-Sibilot, Matteo Giaj Levra
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-116 - Early Immune-Related Adverse Events Under PD-1/PD-L1 Inhibitors Predict Better Progression-Free Survival in NSCLC
09:45 - 09:45 | Presenter: Maxime Boussageon | Author(s): Sandra Ortiz-Cuaran, Sylvie Chabaud, David Pérol, Virginie Avrillon, Bénédicte Mastroianni, Jérôme Fayette, Francois Ghiringhelli, Eve-Marie Neidhardt, Aurélie Swalduz, Valérie Paulus, Coureche Guillaume Kaderbhai, Jean-David Fumet, Pierre Saintigny, Maurice Perol
- Abstract
Loading... -
+
P1.01-124 - Health-Related Quality of Life (HRQoL) Data in a Phase 3 Study of First-Line Brigatinib vs Crizotinib in NSCLC (ALTA-1L)
09:45 - 09:45 | Presenter: Rosario Garcia Campelo | Author(s): Huamao Mark Lin, Maurice Perol, Mohammad Jahanzeb, Sanjay Popat, Yanyan Zhu, Pingkuan Zhang, D. Ross Camidge
- Abstract
Loading...
-
+
P1.04 - Immuno-oncology
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P1.04-30 - Pioneer Study: Precision Immuno-Oncology for Advanced Non-Small Cell Lung Cancer Patients with PD1/L1 ICI Resistance
09:45 - 09:45 | Presenter: Fabrice Barlesi | Author(s): David Pérol, Julien Mazieres, Maurice Perol, Nathalie Varoqueaux, Florence Monville, Clarisse Audigier-Valette, Patricia Barre, François Domergue, Lionel Falchero, Cyril Foa, Ahmed Frikha, Stéphane Hominal, Jacques Le Treut, Sarah Zahi, Marie Roumieux, Daniel Olive, Eric Vivier
- Abstract
Loading...
-
+
IS12 - Symposium by Medscape: Expanding the Therapeutic Landscape Of Advanced NSCLC Targeting HER2 (Not IASLC CME Accredited)
- 07:00 - 08:00
- 9/09/2019
- Location: Hilton Head (1978)
- Type: Industry Symposia & Workshops
- Track:
-
+
MA13 - Going Back to the Roots!
- 14:00 - 15:30
- 9/09/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Maurice Perol, Kaoru Kubota
-
+
MA13.01 - Associations Between Baseline Serum Biomarker Levels and Cachexia/Pre-Cachexia in Pretreated Non-Small Cell Lung Cancer (NSCLC) Patients
14:00 - 14:05 | Presenter: Jeffrey Allen Borgia | Author(s): Gabriela C Lobato, Mary Jo Fidler, Jared D Fialkoff, Maneet Multani, Conner Wakefield, Sanjib Basu, Marta Batus, Philip Bonomi
- Abstract
Loading... -
+
MA13.02 - Incidence of Venous Thromboembolism at the Time of Lung Cancer Diagnosis: A Multicenter, Prospective Observational Trial (Rising-VTE/NEJ037)
14:05 - 14:10 | Presenter: Kosuke Hamai | Author(s): Yukari Tsubata, Naoki Furuya, Tae Hata, Ryota Saito, Takeshi Masuda, Takamasa Hotta, Megumi Hamaguchi, Shoichi Kuyama, Ryoichi Honda, Kikuo Nakano, Masamoto Nakanishi, Kunihiko Funaishi, Masahiro Yamasaki, Nobuhisa Ishikawa, Kazunori Fujitaka, Tetsuya Kubota, Kunihiko Kobayashi, Takeshi Isobe
- Abstract
Loading... -
+
MA13.03 - Retrospective Study of Intrathecal Therapy for Non-Small Cell Lung Cancer (NSCLC) Patients with Leptomeningeal Carcinomatosis
14:10 - 14:15 | Presenter: Noelia Vilariño | Author(s): Juan Antonio Marín, Marta Simó, Roser Velasco, Montserrat Alemany, Maria Jove, Jose Carlos Ruffinelli, Isabel Brao, Monica Arellano, Ramon Palmero Sánchez, Jordi Bruna, Ernest Nadal
- Abstract
Loading... -
+
MA13.04 - Discussant - MA13.01, MA13.02, MA13.03
14:15 - 14:30 | Presenter: Ramaswamy Govindan
- Abstract
No abstract available for this presentation
-
+
MA13.05 - Nab-Paclitaxel Maintenance in Squamous Non-Small Cell Lung Cancer (NSCLC): Updated Results of the Phase III ABOUND.sqm Study
14:30 - 14:35 | Presenter: David R Spigel | Author(s): Robert M Jotte, Santiago Ponce Aix, Laurent Gressot, Daniel Morgensztern, Michael McCleod, Mark A Socinski, Davey Daniel, Oscar Juan, Kathryn F Mileham, HOWARD WEST, Ray Page, Niels Reinmuth, Jeanna Knoble, Olivia Yu Tian, Rafia Bhore, Marianne Wolfsteiner, Teng Jin Ong, Cesare Gridelli, Michael Thomas
- Abstract
Loading... -
+
MA13.06 - Ph3 Study of Maintenance Therapy with S-1 vs BSC After Induction Therapy with Carboplatin + S-1 for Advanced Squamous Cell Lung Cancer (WJOG7512L)
14:35 - 14:40 | Presenter: Kaoru Tanaka | Author(s): Satoshi Morita, Masahiko Ando, Takuma Yokoyama, Atsushi Nakamura, Hiroshige Yoshioka, Takashi Ishiguro, Satoru Miura, Ryo Toyozawa, Tetsuya Oguri, Haruko Daga, Ryo Ko, Akihiro Bessho, Motoko Tachihara, Yasuo Iwamoto, Katsuya Hirano, Yoichi Nakanishi, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Isamu Okamoto
- Abstract
Loading... -
+
MA13.07 - Phase I/II Study of Carboplatin Plus Weekly Nab-Paclitaxel in Aged ≥75 Patients with Squamous-Cell Lung Cancer: TORG1322
14:40 - 14:45 | Presenter: Yoshitaka Zenke | Author(s): Seiji Niho, Shigeki Umemura, Masashi Ishihara, Ryosuke Ochiai, Naoyuki Nogami, Yukio Hosomi, Tsuneo Shimokawa, Takaaki Tokito, Yasushi Goto, Yosuke Miura, Haruhiro Saito, Naoya Hida, Satoshi Ikeda, Hiroshi Tanaka, Naoki Furuya, Toshihiro Misumi, Yuichiro Ohe, Hiroaki Okamoto
- Abstract
Loading... -
+
MA13.08 - Discussant - MA13.05, MA13.06, MA13.07
14:45 - 15:00 | Presenter: Karen L Reckamp
- Abstract
No abstract available for this presentation
-
+
MA13.09 - Cisplatin Sustains Lung Cancer Metastasis Through the Systemic Activation of SDF-1/CXCR4 Axis
15:00 - 15:05 | Presenter: Giulia Bertolini | Author(s): Valeria Cancila, Claudio Tripodo, Gabriella Sozzi, Giuseppe Lo Russo, Orazio Fortunato, Massimo Milione, Giovanni Centonze, Monica Tortoreto, Stefania Scala, Luca Roz
- Abstract
Loading... -
+
MA13.10 - A Phase II Study of Carboplatin and Nab-Paclitaxel for Advanced Non-Small Cell Lung Cancer with Interstitial Lung Disease (HOT1302)
15:05 - 15:10 | Presenter: Hiroshi Yokouchi | Author(s): Hajime Asahina, Satoshi Oizumi, Kei Takamura, Toshiyuki Harada, Masao Harada, Kenya Kanazawa, Yuka Fujita, Tetsuya Kojima, Fumiko Sugaya, Hisashi Tanaka, Ryoichi Honda, Takahiro Ogi, Eiki Kikuchi, Tomoo Ikari, Hirotoshi Dosaka-Akita, Hiroshi Isobe, Masaharu Nishimura
- Abstract
Loading... -
+
MA13.11 - A Randomized Phase III Study of Cisplatin-Polymeric Micelle Paclitaxel vs Cisplatin-Solvent-Based Paclitaxel in 1st Line Advanced NSCLC
15:10 - 15:15 | Presenter: Yi-Long Wu | Author(s): Baohui Han, Meiqi Shi, Haiyan Tu, Aiqin Gu, Cheng Huang, Huijuan Wang, Zhuang Yu, Xiuwen Wang, Lejie Cao, Yongqian Shu, Huaqing Wang, Runxiang Yang, Xingya Li, Jianhua Chang, Yanping Hu, Peng Shen, Yi Hu, Zhongliang Guo, Min Tao, Yiping Zhang, Xunyan Liu, Qian Sun, Xin Zhang, Zuguang Jiang, Junhui Zhao, Feng Chen, Jing Sun, Duan Li, Jinsong Zhou
- Abstract
Loading... -
+
MA13.12 - Discussant - MA13.09, MA13.10, MA13.11
15:15 - 15:30 | Presenter: Lyudmila Bazhenova
- Abstract
No abstract available for this presentation
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.07 - Circulating Tumor DNA Analysis Depicts Potential Mechanisms of Resistance to BRAF-Targeted Therapies in BRAF+ Non-Small Cell Lung Cancer
15:10 - 15:15 | Presenter: Sandra Ortiz-Cuaran | Author(s): Laura Mezquita, Aurélie Swalduz, Mihaela Aldea, Julien Mazieres, CECILE Jovelet, Washington René Chumbi Flores, LUDOVIC Lacroix, Yohan Loriot, Luc Friboulet, Virginie Westeel, Maud Ngocamus, Anne Pradines, Claire Tissot, Christelle Clement Duchene, Christine Raynaud, Xavier Quantin, Radj Gervais, Etienne Brain, Isabelle Monnet, Etienne Giroux Leprieur, Virginie Avrillon, Céline Mahier-Aït Oukhatar, Natalie Hoog-Labouret, Frank De Kievit, Karen Howarth, Jean-Francois Guichou, Clive Morris, Emma Green, Maurice Perol, Benjamin Besse, Jean-Yves Blay, Pierre Saintigny, David Planchard
- Abstract
Loading...